The American Society of Hematology has developed new reference ranges for children and adults with Duffy-null status, a ...
Tactile Systems trading at a deep discount despite double-digit lymphedema growth and sector-leading 77% gross margins. Read ...
India, Nov. 4 -- Advances in immunology, biotechnology, and regenerative medicine depend on access to high-quality human biological materials. Among these resources, umbilical cord blood has become ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...
RNA sequencing data from ∼150,000 samples reveal prevalent public cancer-specific T cell receptors with therapeutic potential.
Learn how colon cancer treatment varies by stage, from surgery for early disease to chemotherapy, targeted therapy, and ...
A retrospective study of 112 DLBCL patients found that a composite HALP-LDH score predicted overall survival more accurately ...
X4 Pharmaceuticals (NASDAQ:XFOR) said it expects to complete enrollment in its pivotal Phase III 4WARD trial of mavorixafor ...